abstract |
The present invention relates to novel pharmaceutical formulations containing (2R, cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one ((-)-2',3'-dideoxy, 3'-thiacytidine, Epivir(R), lamivudine) and their use in medical therapy. |